Cancer Updates | News from The American Cancer Society
Read the latest cancer news from the American Cancer Society.
www.cancer.orgHere are some of the latest cancer news highlights from reputable sources as of now.
-
Immunotherapy advances and approvals
- New data continue to show benefits of personalized immunotherapies for various solid tumors, including updates on CAR-T and TIL therapies. For example, recent press releases and coverage highlight tumor-infiltrating lymphocyte approaches showing responses in metastatic cancers.[3]
-
Cancer deaths and survivorship trends
- The U.S. National Cancer Institute and related bodies report ongoing declines in overall cancer death rates, with continued progress through 2024–2025 and insights into how pandemic years affected cancer screening and outcomes.[3]
-
Breakthroughs in targeted therapies
- Researchers are identifying and testing novel targets (e.g., KRAS inhibitors, new pathways influencing tumor resistance) that could broaden the range of cancers amenable to targeted treatments.[1][3]
-
Early detection and biomarkers
- Studies continue to explore tissue biomarkers and screening tools to identify aggressive cancers earlier, aiding risk stratification and treatment planning.[3]
-
Global research and funding updates
- Cancer charities and research institutes publish news on breakthroughs, coordinated funding, and collaborative initiatives to accelerate discovery across cancer types, including rare cancers and pediatric tumors.[2][4]
Where to look for the freshest updates
- U.S. National Cancer Institute (NCI) News & Events: latest press releases and scientific advances.[3]
- Cancer charities and research institutes with weekly or monthly updates (e.g., Worldwide Cancer Research).[4][2]
- Major cancer news outlets aggregating oncology coverage (e.g., STAT, Cancer.org family sites).[7][9][1]
Would you like me to pull the very latest items from a specific outlet (for example, NCI or a particular charity) and summarize those with direct links? I can also tailor the briefing to a particular cancer type or treatment area (immunotherapy, targeted therapy, screening, or survivorship).